Literature DB >> 304825

K-lymphocytes (killer-cells) in Crohn's disease and acute virus B-hepatitis.

R Eckhardt, P Kloos, M P Dierich, K H Meyer zum Büschenfelde.   

Abstract

Total lymphocyte counts, B-, T-, C'3 receptor-bearing lymphocytes, and K-cell activity were studied in peripheral blood in patients with Crohn's disease and inflammatory liver disease. Patients with active untreated Crohn's disease and acute virus B hepatitis exhibited a markedly increased K-cell activity measured in a plaque assay when compared with normal controls (P less than 0.01). Patients with immunosuppressive treated Crohn's disease, HBsAg-positive chronic active hepatitis, and cirrhosis of the liver showed only a slight increase of K-cell activity (P less than 0.01). In the postacute phase of hepatitis (four to 12 weeks from onset) K-cell activity fell to normal levels. The number of B-lymphocytes showed a relative and absolute decrease in all groups of patients. With the exception of patients with acute HBsAg-positive hepatitis and the post-acute phase of hepatitis all the other groups showed statistically decreased absolute numbers for C'3 receptor-bearing lymphocytes. The significant decrease in K-cell activity and the number of T-lymphocytes in Crohn's disease treated with immunosuppressive drugs was interpreted as an effect of azathioprine and prednisone on these lymphocyte subpopulations.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 304825      PMCID: PMC1411840          DOI: 10.1136/gut.18.12.1010

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  38 in total

1.  Immunological aspects of inflammatory bowel disease.

Authors:  P J Whorwell; R Wright
Journal:  Clin Gastroenterol       Date:  1976-05

2.  Antibody-dependent cell-mediated cytotoxicity in selected autoimmune diseases.

Authors:  J L Feldmann; M J Becker; H Moutsopoulos; K Fye; M Blackman; W V Epstein; N Talal
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

3.  A plaque technique for assay and characterization of antibody-dependent cytotoxic effector (K) cells.

Authors:  P Biberfeld; B Wåhlin; P Perlmann; G Biberfeld
Journal:  Scand J Immunol       Date:  1975       Impact factor: 3.487

Review 4.  Evidence for a transmissible agent in Crohn's disease.

Authors:  W L Beeken; D N Mitchell; D R Cave
Journal:  Clin Gastroenterol       Date:  1976-05

5.  Antibody-dependent cell-mediated (K cell) cytotoxicity against isolated hepatocytes in chronic active hepatitis.

Authors:  A M Cochrane; A Moussouros; A D Thomsom; A L Eddleston; R Wiiliams
Journal:  Lancet       Date:  1976-02-28       Impact factor: 79.321

6.  Antibody-dependent cell-mediated cytotoxicity in humans. I. Characterization of the effector cell.

Authors:  G Trinchieri; P Bauman; M De Marchi; Z Tökés
Journal:  J Immunol       Date:  1975-07       Impact factor: 5.422

7.  [Immune response to HBsAg, HBcAg and e-antigen in patients with acute hepatitis and HBsAg carriers with and without liver diseases].

Authors:  K H Meyer zum Büschenfelde; W Arnold; J Knolle; G Hess
Journal:  Z Gastroenterol       Date:  1976-05       Impact factor: 2.000

8.  Immunosuppressive effects of glucocorticosteroids: differential effects of acute vs chronic administration on cell-mediated immunity.

Authors:  J E Balow; D L Hurley; A S Fauci
Journal:  J Immunol       Date:  1975-03       Impact factor: 5.422

Review 9.  Immunological aspects of hepatitis B virus infection.

Authors:  T S Edgington; F V Chisari
Journal:  Am J Med Sci       Date:  1975 Sep-Oct       Impact factor: 2.378

10.  Analysis by a plaque assay of IgG- or IgM- dependent cytolytic lymphocytes in human blood.

Authors:  B Wåhlin; H Perlmann; P Perlmann
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307

View more
  9 in total

1.  Gut mucosal lymphocytes in inflammatory bowel disease: isolation and preliminary functional characterization.

Authors:  C Fiocchi; J R Battisto; R G Farmer
Journal:  Dig Dis Sci       Date:  1979-09       Impact factor: 3.199

2.  Depressed spontaneous cell-mediated cytotoxicity in Crohn's disease.

Authors:  W L Beeken; B R Macpherson; R M Gundel; S St Andre-Ukena; S G Wood; D L Sylwester
Journal:  Clin Exp Immunol       Date:  1983-02       Impact factor: 4.330

3.  Antibody-dependent cellular cytotoxicity in recurrent aphthous ulceration.

Authors:  J S Greenspan; N Gadol; J A Olson; N Talal
Journal:  Clin Exp Immunol       Date:  1981-06       Impact factor: 4.330

4.  NK and K cell activity of human blood: differences according to sex, age, and disease.

Authors:  J Penschow; I R Mackay
Journal:  Ann Rheum Dis       Date:  1980-02       Impact factor: 19.103

5.  Immune status in Crohn's disease. 4. In vitro antibody dependent cell mediated cytotoxicity in peripheral blood.

Authors:  I O Auer; E Ziemer
Journal:  Klin Wochenschr       Date:  1980-08-01

6.  Antibody dependent cellular cytotoxicity in chronic active liver diseases.

Authors:  S Kakumu; R Hotta; J Kuriki
Journal:  Gastroenterol Jpn       Date:  1981

7.  T lymphocyte subsets in inflammatory bowel disease: peripheral blood.

Authors:  W S Selby; D P Jewell
Journal:  Gut       Date:  1983-02       Impact factor: 23.059

8.  Human colonic intraepithelial and lamina proprial lymphocytes: cytotoxicity in vitro and the potential effects of the isolation method on their functional properties.

Authors:  M Chiba; W Bartnik; S G ReMine; W R Thayer; R G Shorter
Journal:  Gut       Date:  1981-03       Impact factor: 23.059

9.  Thiopurine use associated with reduced B and natural killer cells in inflammatory bowel disease.

Authors:  James D Lord; Donna M Shows
Journal:  World J Gastroenterol       Date:  2017-05-14       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.